Allergy Immunotherapy Market Research Report - Global Forecast till 2023

Global Allergy Immunotherapy Market Research Report: Information, by Allergy Type (Allergic Rhinitis, Allergic Asthma, Peanut Allergy, Cat Allergy and others), Treatment (Sublingual Immunotherapy, Subcutaneous Immunotherapy (SCIT) and Specific Immunotherapy (SIT)) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023

ID: MRFR/Pharma/0988-CR | August 2019 | Region: Global | 88 pages

The Global Allergy Immunotherapy Market is expected to register 10.85% CAGR and reach USD 4,324.7 million by 2023. Allergy immunotherapy is a disease-adapting therapy that is effective for the treatment of allergic rhinitis/conjunctivitis, allergic asthma, peanuts allergy, cat allergy, and stinging insect hypersensitivity. This involves the regular administration of gradually increasing the dose of allergen extracts into the patient’s body over a certain period.


The launch of new sublingual immunotherapies in emerging economies and the presence of major players in allergen immunotherapy market is expected to drive the market during the forecast period. However, the restricted healthcare spending in the underserved market of Europe will restrain the growth.


Market Dynamics


The growing unmet needs of novel targeted drugs, which are used to treat the disease conditions, has created growth opportunities for the market players. To capture this opportunity, many companies are investing in research and development to develop targeted drugs for various allergic conditions. To increase their share in the market, companies are introducing more and more allergen immunotherapy tablets (AITs) in potential markets. For instance, products such as Mitizax (HDM) tablets, Merck’s Grastek (grass), Ragwitek (ragweed), and Greer’s Oralair (grass) were launched in the US in between 2014–2015. Such a vast population suffering from kidney disease boosts market growth during the forecast period.


Global Allergy Immunotherapy Market, by Treatment, 2016 & 2023 (USD Million)
 Allergy Immunotherapy Market


Source: MRFR Analysis


Segmentation


Based on allergy type, the global allergy immunotherapy market has been segmented into allergic rhinitis, allergic asthma, peanut allergy, cat allergy, and others.


Based on treatment, the global allergy immunotherapy market has been categorized as sublingual immunotherapy, subcutaneous immunotherapy (SCIT), and specific immunotherapy (SIT).


Global Allergy Immunotherapy Market Share, 2016 (%)
 Allergy Immunotherapy Market


Source: MRFR Analysis


Regional Analysis


The global allergy immunotherapy market, based on region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.


Europe holds the largest share of the global allergy immunotherapy market. This can be attributed to the rise in prevalence of chronic diseases such as allergy, asthma, diabetes, and hypertension and the presence of several pharmaceutical companies in the region. Europe held 32% in the global allergy immunotherapy market in 2016.


The Americas is expected to account for the second-largest market share during the forecast period. North America is expected to dominate the market in the region, mainly due to the high prevalence of allergic rhinitis & skin allergy and increasing awareness regarding the treatment of allergies.


Asia-Pacific is estimated to be the fastest-growing region in the global market due to the increasing incidents of infectious diseases, improving healthcare infrastructure, and rising awareness about allergy immunotherapy.


The allergy immunotherapy market in the Middle East & Africa is expected to grow significantly due to the high prevalence of nasal allergies in Saudi Arabia, Kuwait, and the UAE.  


Key Players


The prominent players in the global allergy immunotherapy market are ALK Abello A/S (UK), Allergy Therapeutic (UK), Circassia (UK), DBV Technologies (UK), Stallergenes Greer (UK), Merck KGaA (Allergopharma) (UK), and HAL Allergy Group (UK).


Some of the key strategies followed by players operating in the global allergy immunotherapy market were innovation, product development, and acquisition & mergers.



  • In January 2017, ALK Abello A/S acquired the operating assets in Allergy Laboratory of Oklahoma Inc. and Crystal Labs LLC.



  • In October 2017, DBV Technologies entered into a research and development agreement with Stallergenes S.A. for the treatment of birch allergy.



  • In January 2017, Merck acquired BioControl to strengthen its capabilities in food safety testing.


Market Segmentation


Global Allergy Immunotherapy Market, by Allergy Type



  • Allergic Rhinitis

  • Allergic Asthma

  • Peanut Allergy

  • Cat Allergy

  • Others


Global Allergy Immunotherapy Market, by Treatment



  • Sublingual Immunotherapy

  • Subcutaneous Immunotherapy (SCIT)

  • Specific Immunotherapy (SIT)


Global Allergy Immunotherapy Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Company Profiles of Other Key Players

    • Biomay AG

    • Holister Stier

    • Leti



  • Allergy Immunotherapy Market, Industry Trends


Intended Audience



  • Pharmaceutical companies

  • Contract research manufacturing organizations

  • Research & development organizations

  • Academic institutes



Frequently Asked Questions (FAQ) :


Allergy Immunotherapy Market is projected to grow at a 10.85%CAGR between 2014-2023.

Allergy Immunotherapy Market is predicted to touch USD 4,324.7 million by 2023.

Europe is predicted to spearhead the Allergy Immunotherapy Market.

Notable players profiled in the Allergy Immunotherapy Market include HAL Allergy Group (UK), Merck KGaA (Allergopharma) (UK), Stallergenes Greer (UK), DBV Technologies (UK), Circassia (UK), Allergy Therapeutic (UK), and ALK Abello A/S (UK).

Restricted healthcare spending may deter market growth.

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

USD YEN EURO GBP INR
TABLE OF CONTENT

2.1 Introduction 18

2.2 Scope of Study 18

2.3 Research Objective 19

2.4 Assumptions & Limitations 19

2.4.1 Assumptions 19

2.4.2 Limitations 19

2.5 Market Structure 20

3.1 Research Process 21

3.2 Primary Research 22

3.3 Secondary Research 22

3.4 Market Size Estimation 22

3.5 Forecast Model 24

4.1 Introduction 25

4.2 Drivers 25

4.2.1 Launch of New sublingual Immunotherapies in emerging Economies will Drive the Growth of the Market 25

4.2.2 Major Players are introducing Several Allergen Immunotherapy Tablets (AITs) in Potential Markets 26

4.2.3 Increase in risk Factors Causing Allergies 26

4.2.4 Rising Screening for Allergy and reimbursement Scenario 26

4.3 Restraint 27

4.3.1 Restricted Healthcare Spending in underserved Market of Europe will Restrain the Growth 27

4.4 Opportunity 27

4.4.1 Allergy Immune Therapies will be Launched in the US. 27

4.5 Challenges 28

4.5.1 High Cost of Allergy Immunotherapy 28

4.6 Micro Economic Indicators 28

5.1 Porter’s Five Forces Model 30

5.1.1 Bargaining Power of Suppliers 31

5.1.2 Bargaining Power of Buyers 31

5.1.3 Threat of New Entrants 31

5.1.4 Threat of Substitutes 31

5.1.5 Intensity of Rivalry 31

5.2 Supply Chain Analysis 32

5.2.1 R&D 32

5.2.2 Parts Manufacturing 33

5.2.3 Distribution 33

5.2.4 Marketing & Sales 33

5.2.5 Post-Sales Monitoring 33

5.3 Pricing Analysis 33

5.4 Investment Opportunity Analysis 34

5.5 Merger and Acquisition Landscape 35

6.1 Subcutaneous Immunotherapy (SCIT) 37

6.2 Sublingual Immunotherapy (SLIT) 38

7.1 Rhinitis 40

7.2 Asthma 40

7.3 Eye Allergy 41

7.4 Skin Allergy 41

8.1 Hospitals 43

8.2 Clinics 43

8.3 Diagnostic Centers 44

9.1 Americas 46

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.1 North America 48

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.1.1 US 51

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.1.2 Canada 53

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2 Latin America 55

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2.1 Brazil 57

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2.2 Mexico 59

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2.3 Argentina 61

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2.4 Columbia 63

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2.5 Chile 64

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2.6 Rest of Latin America 66

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.3 South America 67

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.3.1 Bolivia 70

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.3.2 Ecuador 73

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.3.3 Peru 75

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.3.4 Venezuela 77

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.3.5 Uruguay 78

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2 Europe 80

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1 Western Europe 82

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.1 Germany 84

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.2 France 86

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.3 UK 88

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.4 Italy 90

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.5 Spain 92

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.6 Russia 94

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.7 Rest of Western Europe 96

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.2 Central Europe 97

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.2.1 Switzerland 99

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.2.2 Slovenia 101

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.3 Eastern Europe 103

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.4 Greece 105

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.5 Rest of Eastern Europe 107

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3 Asia-Pacific 109

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3.1 Japan 111

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3.2 China 113

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3.3 India 115

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3.4 South Korea 117

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3.5 Australia 118

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3.6 New Zealand 120

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.4 Middle East & Africa 121

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.5 Middle East 124

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.6 Africa 125

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

11.1 ALK Abello A/S 129

11.1.1 Overview 129

11.1.2 Product/Business Overview 129

11.1.3 Financial Overview 129

11.1.4 Key Development 131

11.1.5 SWOT Analysis 131

11.2 Allergy Therapeutics 132

11.2.1 Company Overview 132

11.2.2 Product/Business Segment Overview 132

11.2.3 Financial Overview 132

11.2.4 Key Development 133

11.2.5 SWOT Analysis 134

11.3 Circassia 135

11.3.1 Company Overview 135

11.3.2 Product/Business Segment Overview 135

11.3.3 Financial Overview 135

11.3.4 Key Development 136

11.3.5 SWOT Analysis 137

11.4 DBV Technologies 138

11.4.1 Company Overview 138

11.4.2 Product/Business Segment Overview 138

11.4.3 Financial Overview 138

11.4.4 Key Development 139

11.4.5 SWOT Analysis 139

11.5 Stallergenes Greer 140

11.5.1 Company Overview 140

11.5.2 Product/Business Segment Overview 140

11.5.3 Financial Overview 140

11.5.4 Key Development 142

11.5.5 SWOT Analysis 142

11.6 Merck KGaA (Allergopharma) 143

11.6.1 Company Overview 143

11.6.2 Product/Business Segment Overview 143

11.6.3 Financial Overview 144

11.6.4 Key Development 145

11.6.5 SWOT Analysis 145

11.7 HAL Allergy Group 146

11.7.1 Company Overview 146

11.7.2 Product/Business Segment Overview 146

11.7.3 Financial Overview 146

11.7.4 Key Development 146

11.7.5 SWOT Analysis 147

12.1 Key Findings 148

12.1.1 From CEO’s View Point 148

12.2 Key Companies To Watch 148

13.1 Discussion Blue Print 149

TABLE 1 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY USDMILLION 2014–2023 36

TABLE 2 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SUBCUTANEOUS IMMUNOTHERAPY (SCIT) USDMILLION 2014–2023 37

TABLE 3 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SUBLINGUAL IMMUNOTHERAPY USDMILLION 2014–2023 38

TABLE 4 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPES OF ALLERGIES USD MILLION 2014–2023 39

TABLE 5 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR RHINITIS USD MILLION 2014–2023 40

TABLE 6 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR ASTHMA USD MILLION 2014–2023 40

TABLE 7 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR EYE ALLERGY USD MILLION 2014–2023 41

TABLE 8 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SKIN ALLERGY USD MILLION 2014–2023 41

TABLE 9 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 42

TABLE 10 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR HOSPITALS USD MILLION 2014–2023 43

TABLE 11 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR CLINICS USD MILLION 2014–2023 43

TABLE 12 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR DIAGNOSTIC CENTERS USD MILLION 2014–2023 44

TABLE 13 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2014–2023 45

TABLE 14 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2014–2023 46

TABLE 15 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 47

TABLE 16 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 47

TABLE 17 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 48

TABLE 18 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2014–2023 48

TABLE 19 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 49

TABLE 20 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 50

TABLE 21 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 50

TABLE 22 US ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 51

TABLE 23 US ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 51

TABLE 24 US ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 53

TABLE 25 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 53

TABLE 26 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 54

TABLE 27 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 54

TABLE 28 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2014–2023 55

TABLE 29 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 56

TABLE 30 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 56

TABLE 31 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 57

TABLE 32 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 57

TABLE 33 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 58

TABLE 34 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 58

TABLE 35 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 59

TABLE 36 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 59

TABLE 37 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 61

TABLE 38 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 61

TABLE 39 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 62

TABLE 40 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 62

TABLE 41 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 63

TABLE 42 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 63

TABLE 43 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 64

TABLE 44 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 64

TABLE 45 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 65

TABLE 46 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 65

TABLE 47 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 66

TABLE 48 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 66

TABLE 49 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 67

TABLE 50 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2014–2023 67

TABLE 51 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 68

TABLE 52 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 69

TABLE 53 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 69

TABLE 54 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 70

TABLE 55 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 70

TABLE 56 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 72

TABLE 57 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 73

TABLE 58 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 73

TABLE 59 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 75

TABLE 60 PERU ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 75

TABLE 61 PERU ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 76

TABLE 62 PERU ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 76

TABLE 63 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 77

TABLE 64 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 77

TABLE 65 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 78

TABLE 66 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 78

TABLE 67 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 79

TABLE 68 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 79

TABLE 69 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2014–2023 80

TABLE 70 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 81

TABLE 71 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 81

TABLE 72 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 82

TABLE 73 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2014–2023 82

TABLE 74 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 83

TABLE 75 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 84

TABLE 76 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 84

TABLE 77 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 85

TABLE 78 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 85

TABLE 79 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 86

TABLE 80 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 86

TABLE 81 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 87

TABLE 82 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 87

TABLE 83 UK ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 88

TABLE 84 UK ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 88

TABLE 85 UK ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 90

TABLE 86 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 90

TABLE 87 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 91

TABLE 88 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 91

TABLE 89 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 92

TABLE 90 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 92

TABLE 91 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 94

TABLE 92 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 94

TABLE 93 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 95

TABLE 94 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 95

TABLE 95 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 96

TABLE 96 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 96

TABLE 97 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 97

TABLE 98 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS USD MILLION 2014–2023 97

TABLE 99 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 98

TABLE 100 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 99

TABLE 101 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 99

TABLE 102 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 100

TABLE 103 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 100

TABLE 104 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 100

TABLE 105 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 101

TABLE 106 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 102

TABLE 107 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 102

TABLE 108 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS USD MILLION 2014–2023 103

TABLE 109 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 103

TABLE 110 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 104

TABLE 111 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 104

TABLE 112 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 105

TABLE 113 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 105

TABLE 114 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 107

TABLE 115 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 107

TABLE 116 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 108

TABLE 117 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 108

TABLE 118 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2014–2023 109

TABLE 119 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 110

TABLE 120 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 110

TABLE 121 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 111

TABLE 122 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 111

TABLE 123 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 112

TABLE 124 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 112

TABLE 125 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 113

TABLE 126 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 113

TABLE 127 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 115

TABLE 128 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 115

TABLE 129 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 116

TABLE 130 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 116

TABLE 131 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 117

TABLE 132 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 117

TABLE 133 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 118

TABLE 134 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 118

TABLE 135 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 119

TABLE 136 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 119

TABLE 137 REST OF ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 120

TABLE 138 NEW ZEALAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 120

TABLE 139 NEW ZEALAND PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 121

TABLE 140 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2014–2023 121

TABLE 141 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 122

TABLE 142 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 123

TABLE 143 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 123

TABLE 144 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 124

TABLE 145 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 124

TABLE 146 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 125

TABLE 147 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2014–2023 125

TABLE 148 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2014–2023 126

TABLE 149 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2014–2023 126

TABLE 150 ALK-ABELLÓ A/S: KEY DEVELOPMENT 131

TABLE 151 ALLERGY THERAPEUTICS : KEY DEVELOPMENT 133

TABLE 152 CIRCASSIA : KEY DEVELOPMENT 136

TABLE 153 DBV TECHNOLOGIES: KEY DEVELOPMENT 139

TABLE 154 STALLERGENES GREER: KEY DEVELOPMENT 142

TABLE 155 MERCK KGAA: KEY DEVELOPMENT 145

TABLE 156 HAL ALLERGY GROUP: KEY DEVELOPMENT 146

FIGURE 1 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY, 2016 (%) 15

FIGURE 2 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY, 2016 (%) 16

FIGURE 3 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS, 2016 (%) 16

FIGURE 4 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION, 2016 (%) 17

FIGURE 5 GLOBAL ALLERGY IMMUNOTHERAPY MARKET: MARKET STRUCTURE 20

FIGURE 6 RESEARCH PROCESS 21

FIGURE 7 PORTERS FIVE FORCES MODEL 30

FIGURE 8 SUPPLY CHAIN: ALLERGY IMMUNOTHERAPY 32

FIGURE 9 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY USD MILLION 2016 & 2023 36

FIGURE 10 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGIES USD MILLION 2016 & 2023 39

FIGURE 11 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2016 & 2023 42

FIGURE 12 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2016 & 2023 45

FIGURE 13 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY REGION MARKET SHARE 2016 (%) 46

FIGURE 14 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY MARKET SHARE 2016 (%) 49

FIGURE 15 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY MARKET SHARE 2016 (%) 55

FIGURE 16 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY MARKET SHARE 2016 (%) 68

FIGURE 17 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2016 & 2023 80

FIGURE 18 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY MARKET SHARE 2016 (%) 83

FIGURE 19 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS MARKET SHARE 2016 (%) 98

FIGURE 20 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY REGION USDMILLION 2016 & 2023 109

FIGURE 21 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2016 & 2023 122

FIGURE 22 GLOBAL ALLERGY IMMUNOTHERAPY MARKET: COMPANY SHARE ANALYSIS 127

FIGURE 23 AMERICAS ALLERGY IMMUNOTHERAPY MARKET: COMPANY SHARE ANALYSIS 128

FIGURE 24 EUROPE ALLERGY IMMUNOTHERAPY MARKET: COMPANY SHARE ANALYSIS 128

FIGURE 25 ALK-ABELLÓ A/S: RECENT FINANCIAL 129

FIGURE 26 ALK-ABELLÓ A/S: BUSINESS REVENUE MIX (2015) 129

FIGURE 27 ALK-ABELLÓ A/S: GEOGRAPHIC REVENUE MIX 130

FIGURE 28 ALK-ABELLÓ A/S: SWOT ANALYSIS 131

FIGURE 29 ALLERGY THERAPEUTICS : RECENT FINANCIAL 132

FIGURE 30 ALLERGY THERAPEUTICS : GEOGRAPHIC REVENUE MIX 133

FIGURE 31 ALLERGY THERAPEUTICS : SWOT ANALYSIS 134

FIGURE 32 CIRCASSIA : RECENT FINANCIAL 135

FIGURE 33 CIRCASSIA : GEOGRAPHIC REVENUE MIX 136

FIGURE 34 CIRCASSIA : SWOT ANALYSIS 137

FIGURE 35 DBV TECHNOLOGIES: RECENT FINANCIAL 138

FIGURE 36 DBV TECHNOLOGIES: SWOT ANALYSIS 139

FIGURE 37 STALLERGENES GREER: RECENT FINANCIAL 140

FIGURE 38 STALLERGENES GREER: BUSINESS REVENUE MIX (2015) 140

FIGURE 39 STALLERGENES GREER: GEOGRAPHIC REVENUE MIX 141

FIGURE 40 STALLERGENES GREER: SWOT ANALYSIS 142

FIGURE 41 MERCK KGAA: RECENT FINANCIAL 144

FIGURE 42 MERCK KGAA: GEOGRAPHIC REVENUE MIX 144

FIGURE 43 MERCK KGAA: SWOT ANALYSIS 145

FIGURE 44 HAL ALLERGY GROUP: SWOT ANALYSIS 147